CDC20 and Familial prostate cancer: In this study, a pan-cancer analysis was performed to analyze the role of Cdc20 in human cancers, including pancreatic cancer, breast cancer, kidney cancer, prostate cancer, colorectal cancer, lung cancer, glioblastomas, bladder, hepatocellular carcinoma, and other cancers, at transcriptomic and proteomic levels.